Meiho University Institutional Repository:Item 987654321/3486
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 2876/3793 (76%)
造访人次 : 3856193      在线人数 : 437
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于MUIR ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.meiho.edu.tw/ir/handle/987654321/3486


    题名: LINEZOLID INDUCED THROMBOCYTOPENIA IN A PATIENT WITH RENAL INSUFFICIENCY: A CASE REPORTAND A RETROSPECTIVE CASE STUDY
    作者: JWu;CHWen;YTJang;HSChen
    日期: 2017-12-15
    上传时间: 2017-12-15T09:10:29Z (UTC)
    摘要: Linezolid is a new antimicrobial agent with a broad
    spectrum of activity against all clinically important gram positive
    bacteria, including methicillin resistant Staphylococcus aureus
    (MRSA) and vancomycin resistant enterococci (VRE). The incidence
    of linezolid induced thrombocytopenia was reported to be
    2.4% in phase III trials. Clearance of linezolid is not altered in
    patents with renal insufficiency and no dose adjustment is necessary.
    Therefore, linezolid is a suitable and reasonable drug of
    choice for patients with renal insufficiency who have MRSA or
    VRE infection. Moreover, renal insufficiency is also known to
    cause thrombocytopenia.
    显示于类别:[資訊科技系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    溫俊皓(part)EAHP 2015 abstractbook2016 (3).pdf46KbAdobe PDF1417检视/开启


    检视Licence

    在MUIR中所有的数据项都受到原著作权保护.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈